• By MedPageToday   -   Jan 24, 2021

    ICI COLITIS MORE COMMON IN METASTATIC DISEASE

    Risk factors for adverse colitis-related outcomes among patients undergoing immune checkpoint inhibitor treatment for malignancy included...

  • By MedPageToday   -   Jan 24, 2021

    SITAGLIPTIN ADDED TO STANDARD PROPHYLAXIS MAY REDUCE INCIDENCE OF GVHD

    Study Authors: Sherif S. Farag, Mohammad Abu Zaid, et al.; Paul J. Martin Target Audience and Goal Statement: Oncologists, hematologists,...

  • Op-Ed: Los Angeles EMS Is Making the Right Call By MedPageToday   -   Jan 24, 2021

    OP-ED: LOS ANGELES EMS IS MAKING THE RIGHT CALL

    Recently, Los Angeles County's Emergency Medical Services Agency has been in the news for its decision to stop transporting cardiac...

    Hospital
  • Ozempic Seeking High Dose OK; Thyroid Cancer Overdiagnosed in Kids? By MedPageToday   -   Jan 24, 2021

    OZEMPIC SEEKING HIGH DOSE OK; THYROID CANCER OVERDIAGNOSED IN KIDS?

    Novo Nordisk filed for FDA approval of its once-weekly GLP-1 receptor agonist Ozempic at a higher dose of 2.0 mg. It's currently available...

    Injection, Injections, Cancer
  • By MedPageToday   -   Jan 24, 2021

    DIETS EASE SYMPTOMS IN CROHN'S

    Both the Mediterranean diet and the Specific Carbohydrate diet were effective for symptom reduction in patients with Crohn's disease,...

    Diet
  • Op-Ed: Telehealth Is Not Just Technology By MedPageToday   -   Jan 24, 2021

    OP-ED: TELEHEALTH IS NOT JUST TECHNOLOGY

    The COVID-19 pandemic has advanced the use of telehealth throughout the country, but the need to reach more patients, improve quality...

  • By MedPageToday   -   Jan 23, 2021

    LOW-DOSE IL-2 SHOWS PROMISE IN COLITIS

    Low doses of the recombinant T-cell growth factor interleukin 2 were well tolerated among patients with moderate-to-severe ulcerative...

  • Do Mask-Wearing Policies Make a Difference? By MedPageToday   -   Jan 23, 2021

    DO MASK-WEARING POLICIES MAKE A DIFFERENCE?

    You passed medical training, now see if you can pass our weekly quiz

  • By MedPageToday   -   Jan 23, 2021

    CANCER PATIENTS ALSO MISUSE OPIOIDS: HOW CAN WE ID THOSE AT RISK?

    Study Authors: Sriram Yennurajalingam, Joseph Arthur, et al. Target Audience and Goal Statement: Oncologists, pain management specialists,...

    Cancer
  • By MedPageToday   -   Jan 23, 2021

    INTESTINAL BIOMARKERS RESPOND TO OZANIMOD

    Treatment with oral ozanimod reduced markers of intestinal inflammation among patients with moderately to severely active ulcerative...

  • Impact of Masks; High vs Low Blood Oxygen: It's TTHealthWatch! By MedPageToday   -   Jan 23, 2021

    IMPACT OF MASKS; HIGH VS LOW BLOOD OXYGEN: IT'S TTHEALTHWATCH!

    TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine,...

  • COVID-19 Poses Special Challenges to Cancer Care By MedPageToday   -   Jan 23, 2021

    COVID-19 POSES SPECIAL CHALLENGES TO CANCER CARE

    This story was originally published on March 25, 2020. As part of MedPage Today's review of top stories in 2020, we are republishing...

    Cancer
  • Lessons Learned About COVID and Cancer By MedPageToday   -   Jan 23, 2021

    LESSONS LEARNED ABOUT COVID AND CANCER

    In March of 2020, during the first U.S. surge of the COVID-19 pandemic, MedPage Today published a story on oncology specialists from...

    Cancer
  • Op-Ed: Leading by Example on COVID Vax Won't Sway Black Community By MedPageToday   -   Jan 23, 2021

    OP-ED: LEADING BY EXAMPLE ON COVID VAX WON'T SWAY BLACK COMMUNITY

    After months of waiting, an effective COVID-19 vaccine is finally here. Our brave medical workers, who have been on the front lines...

    Vaccination
  • I Miss the Waiting Room By MedPageToday   -   Jan 23, 2021

    I MISS THE WAITING ROOM

    "Please wait. The meeting host will let you in soon." I am in the virtual waiting room for my weekly therapy session, the little waiting...

  • Op-Ed: The Cost of Liability By MedPageToday   -   Jan 23, 2021

    OP-ED: THE COST OF LIABILITY

    We'd only been living in Wellington, New Zealand, for 2 weeks when I had my first encounter with Kiwi emergency room care - not as...

  • New First-Line Kidney Cancer Combination Gets FDA Nod By MedPageToday   -   Jan 22, 2021

    NEW FIRST-LINE KIDNEY CANCER COMBINATION GETS FDA NOD

    WASHINGTON - The FDA approved the combination of nivolumab plus cabozantinib on Friday for treating advanced renal cell carcinoma in...

    Cancer
  • Game-Changer for Asymptomatic Alzheimer's Trials? By MedPageToday   -   Jan 22, 2021

    GAME-CHANGER FOR ASYMPTOMATIC ALZHEIMER'S TRIALS?

    Blood tests to screen for amyloid-beta could cut the need for PET scans in half in asymptomatic Alzheimer's research trials, a British...

    Alzheimer
  • Trial Backs Metabolic Surgery as Long-Term Diabetes Cure By MedPageToday   -   Jan 22, 2021

    TRIAL BACKS METABOLIC SURGERY AS LONG-TERM DIABETES CURE

    For long-term diabetes remission, metabolic surgery is an effective option, 10-year data suggested. In a randomized trial of 60 patients...

    Obesity, Diabetes, Cures
  • Track the Vax: Now Comes the Hard Part for Vaccine Priorities By MedPageToday   -   Jan 22, 2021

    TRACK THE VAX: NOW COMES THE HARD PART FOR VACCINE PRIORITIES

    Topic: MedPage Today speaks with two experts to wade through ethical considerations as the U.S. undergoes the largest and fastest mass...

    Vaccination